{"name": "Pearl Therapeutics",
 "permalink": "pearl-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/pearl-therapeutics",
 "homepage_url": "http://www.pearltherapeutics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "650-305-2600",
 "description": "Respiratory Disease research",
 "created_at": "Fri Jun 26 12:32:50 UTC 2009",
 "updated_at": "Mon Jun 10 16:13:17 UTC 2013",
 "overview": "\u003Cp\u003EPearl Therapeutics is developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases, including chronic obstructive pulmonary disease. \u003C/p\u003E\n\n\u003Cp\u003EPearl\u0026#8217;s current focus is on making advanced inhaled therapies available to broad patient populations via familiar and accepted metered dose inhalers.\u003C/p\u003E\n\n\u003Cp\u003EPearl is a privately held company led by a seasoned team of respiratory product development experts.  Pearl aims to offer patients and healthcare providers alternatives that better meet their needs and improve upon the safety and efficacy of existing respiratory therapeutics to achieve better clinical outcomes. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       56],
      "assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],
     [[180,
       68],
      "assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],
     [[180,
       68],
      "assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Charles",
      "last_name": "(Chuck) Bramlage",
      "permalink": "charles-chuck-bramlage",
      "image": null}},
   {"is_past": true,
    "title": "Board Member",
    "person":
     {"first_name": "Howard",
      "last_name": "B. Rosen",
      "permalink": "howard-b-rosen",
      "image":
       {"available_sizes":
         [[[127,
            150],
           "assets/images/resized/0025/7882/257882v1-max-150x150.jpg"],
          [[150,
            176],
           "assets/images/resized/0025/7882/257882v1-max-250x250.jpg"],
          [[150,
            176],
           "assets/images/resized/0025/7882/257882v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$167M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://deals.venturebeat.com/2008/07/03/pearl-therapeutics-ups-its-first-round-funding/",
    "source_description": "Pearl Therapeutics ups its first round funding",
    "raised_amount": 18000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 7,
    "funded_day": 3,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "5AM Ventures",
         "permalink": "5am-ventures",
         "image":
          {"available_sizes":
            [[[150,
               104],
              "assets/images/resized/0004/7316/47316v2-max-150x150.jpg"],
             [[250,
               173],
              "assets/images/resized/0004/7316/47316v2-max-250x250.jpg"],
             [[288,
               200],
              "assets/images/resized/0004/7316/47316v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Nektar Therapeutics",
         "permalink": "nektar-therapeutics",
         "image":
          {"available_sizes":
            [[[150,
               54],
              "assets/images/resized/0005/0890/50890v1-max-150x150.png"],
             [[220,
               80],
              "assets/images/resized/0005/0890/50890v1-max-250x250.png"],
             [[220,
               80],
              "assets/images/resized/0005/0890/50890v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://onbiovc.com/pearl-therapeutics-inc-series-c-15m/",
    "source_description": "Pearl Therapeutics, Inc.: Series C $15M",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 3,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "5AM Ventures",
         "permalink": "5am-ventures",
         "image":
          {"available_sizes":
            [[[150,
               104],
              "assets/images/resized/0004/7316/47316v2-max-150x150.jpg"],
             [[250,
               173],
              "assets/images/resized/0004/7316/47316v2-max-250x250.jpg"],
             [[288,
               200],
              "assets/images/resized/0004/7316/47316v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.fiercebiotech.com/story/pearl-lands-69m-series-c-mid-stage-copd-program/2010-10-19?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Pearl lands $69M Series C for mid-stage COPD program",
    "raised_amount": 69000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 10,
    "funded_day": 19,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "5AM Ventures",
         "permalink": "5am-ventures",
         "image":
          {"available_sizes":
            [[[150,
               104],
              "assets/images/resized/0004/7316/47316v2-max-150x150.jpg"],
             [[250,
               173],
              "assets/images/resized/0004/7316/47316v2-max-250x250.jpg"],
             [[288,
               200],
              "assets/images/resized/0004/7316/47316v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Vatera Healthcare Partners",
         "permalink": "vatera-healthcare-partners",
         "image": null},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://www.finsmes.com/2012/11/pearl-therapeutics-raises-65m-series-financing.html",
    "source_description": "Pearl Therapeutics Raises $65M in Series D Financing",
    "raised_amount": 65000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 11,
    "funded_day": 13,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Vatera Healthcare Partners",
         "permalink": "vatera-healthcare-partners",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "5AM Ventures",
         "permalink": "5am-ventures",
         "image":
          {"available_sizes":
            [[[150,
               104],
              "assets/images/resized/0004/7316/47316v2-max-150x150.jpg"],
             [[250,
               173],
              "assets/images/resized/0004/7316/47316v2-max-250x250.jpg"],
             [[288,
               200],
              "assets/images/resized/0004/7316/47316v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 1150000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.reuters.com/article/2013/06/10/us-astrazeneca-pearl-idUSBRE95904U20130610?feedType=RSS\u0026feedName=businessNews",
   "source_description": "AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion",
   "acquired_year": 2013,
   "acquired_month": 6,
   "acquired_day": 10,
   "acquiring_company":
    {"name": "AstraZeneca",
     "permalink": "astrazeneca",
     "image":
      {"available_sizes":
        [[[150,
           37],
          "assets/images/resized/0006/4083/64083v1-max-150x150.png"],
         [[176,
           44],
          "assets/images/resized/0006/4083/64083v1-max-250x250.png"],
         [[176,
           44],
          "assets/images/resized/0006/4083/64083v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "Corporate Headquarters",
    "address1": "200 Saginaw Drive",
    "address2": "",
    "zip_code": "94063",
    "city": "Redwood City",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.502169,
    "longitude": -122.217727}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        84],
       "assets/images/resized/0005/0878/50878v1-max-150x150.jpg"],
      [[250,
        140],
       "assets/images/resized/0005/0878/50878v1-max-250x250.jpg"],
      [[450,
        253],
       "assets/images/resized/0005/0878/50878v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}